OBJECTIVE: To analyse changes in clinical indications for community antibiotic prescribing for children in the UK between 1996 and 2006 and relate these findings to the new NICE guidelines for the treatment of upper respiratory tract infections in children. STUDY DESIGN: Retrospective cohort study. METHOD: The IMS Health Mediplus database was used to obtain annual antibiotic prescribing rates and associated clinical indications in 0-18-year-old patients between 1 January 1996 and 31 December 2006 in the UK. RESULTS: Antibiotic prescribing declined by 24% between 1996 and 2000 but increased again by 10% during 2003-2006. Respiratory tract infection was the most common indication for which an antibiotic was prescribed, followed by "abnormal signs and symptoms", ear and skin infections. Antibiotic prescriptions for respiratory tract infections have decreased by 31% (p<0.01) mainly because of reduced prescribing for lower respiratory tract infections (56% decline, p<0.001) and specific upper respiratory tract infections including tonsillitis/pharyngitis (48% decline, p<0.001) and otitis (46% decline, p<0.001). Prescribing for non-specific upper respiratory tract infection increased fourfold (p<0.001). Prescribing for "abnormal signs and symptoms" increased significantly since 2001 (40% increase, p<0.001). CONCLUSION: There has been a marked decrease in community antibiotic prescribing linked to lower respiratory tract infection, tonsillitis, pharyngitis and otitis. Overall prescribing is now increasing again but is associated with non-specific upper respiratory tract infection diagnoses. General practitioners may be avoiding using diagnoses where formal guidance suggests antibiotic prescribing is not indicated. The new NICE guidance on upper respiratory tract infections is at risk of being ignored.
OBJECTIVE: To analyse changes in clinical indications for community antibiotic prescribing for children in the UK between 1996 and 2006 and relate these findings to the new NICE guidelines for the treatment of upper respiratory tract infections in children. STUDY DESIGN: Retrospective cohort study. METHOD: The IMS Health Mediplus database was used to obtain annual antibiotic prescribing rates and associated clinical indications in 0-18-year-old patients between 1 January 1996 and 31 December 2006 in the UK. RESULTS: Antibiotic prescribing declined by 24% between 1996 and 2000 but increased again by 10% during 2003-2006. Respiratory tract infection was the most common indication for which an antibiotic was prescribed, followed by "abnormal signs and symptoms", ear and skin infections. Antibiotic prescriptions for respiratory tract infections have decreased by 31% (p<0.01) mainly because of reduced prescribing for lower respiratory tract infections (56% decline, p<0.001) and specific upper respiratory tract infections including tonsillitis/pharyngitis (48% decline, p<0.001) and otitis (46% decline, p<0.001). Prescribing for non-specific upper respiratory tract infection increased fourfold (p<0.001). Prescribing for "abnormal signs and symptoms" increased significantly since 2001 (40% increase, p<0.001). CONCLUSION: There has been a marked decrease in community antibiotic prescribing linked to lower respiratory tract infection, tonsillitis, pharyngitis and otitis. Overall prescribing is now increasing again but is associated with non-specific upper respiratory tract infection diagnoses. General practitioners may be avoiding using diagnoses where formal guidance suggests antibiotic prescribing is not indicated. The new NICE guidance on upper respiratory tract infections is at risk of being ignored.
Authors: Alan C Kinlaw; Til Stürmer; Jennifer L Lund; Lars Pedersen; Michael D Kappelman; Julie L Daniels; Trine Frøslev; Christina D Mack; Henrik Toft Sørensen Journal: Pediatrics Date: 2017-08-14 Impact factor: 7.124
Authors: Christopher C Butler; Kathryn O'Brien; Timothy Pickles; Kerenza Hood; Mandy Wootton; Robin Howe; Cherry-Ann Waldron; Emma Thomas-Jones; William Hollingworth; Paul Little; Judith Van Der Voort; Jan Dudley; Kate Rumsby; Harriet Downing; Kim Harman; Alastair D Hay Journal: Br J Gen Pract Date: 2015-04 Impact factor: 5.386
Authors: Talley A Vodicka; Matthew Thompson; Patricia Lucas; Carl Heneghan; Peter S Blair; David I Buckley; Niamh Redmond; Alastair D Hay Journal: Br J Gen Pract Date: 2013-07 Impact factor: 5.386
Authors: Gijs Elshout; Yvette van Ierland; Arthur M Bohnen; Marcel de Wilde; Rianne Oostenbrink; Henriëtte A Moll; Marjolein Y Berger Journal: Br J Gen Pract Date: 2013-07 Impact factor: 5.386
Authors: V Papaevangelou; A Rousounides; A Hadjipanagis; A Katsioulis; M Theodoridou; C Hadjichristodoulou Journal: Antimicrob Agents Chemother Date: 2011-12-12 Impact factor: 5.191
Authors: Kathryn O'Brien; Thomas Wyn Bellis; Mark Kelson; Kerenza Hood; Christopher C Butler; Adrian Edwards Journal: Br J Gen Pract Date: 2015-09 Impact factor: 5.386
Authors: Gijs Elshout; Marijke Kool; Arthur M Bohnen; Bart W Koes; Henriëtte A Moll; Marjolein Y Berger Journal: Br J Gen Pract Date: 2015-09 Impact factor: 5.386
Authors: Sonia Saxena; Zareen Ismael; Macey L Murray; Charlotte Barker; Ian C K Wong; Mike Sharland; Paul F Long Journal: Br J Gen Pract Date: 2014-04 Impact factor: 5.386